Feng Guo
Founder bij Jiaxing Zhijun Investment Management Co., Ltd.
Profiel
Feng Guo is the founder of Jiaxing Zhijun Investment Management Co., Ltd.
He currently holds positions as Executive Director in the Investment Banking Division at Guoxin Securities Co., Ltd.
and Director at AnPac Bio-Medical Technology (Lishui) Co., Ltd.
Previously, he held the position of Director at China Renaissance Capital Investment (China), Inc. from 2015 to 2017 and Director at Fresh2 Group Ltd.
from 2018 to 2022.
Mr. Guo received his graduate degree from Shanghai University of Finance & Economics in 2004 and his undergraduate degree from East China University of Political Science & Law in 2002.
Actieve functies van Feng Guo
| Bedrijven | Functie | Begin |
|---|---|---|
| Jiaxing Zhijun Investment Management Co., Ltd. | Founder | - |
Guoxin Securities Co., Ltd.
 Guoxin Securities Co., Ltd. Investment Banks/BrokersFinance Guoxin Securities Co., Ltd. is a Chinese comprehensive securities company that offers stock investment and trading services. The private company is based in China, specifically in Pudong, China. With over 20 years of development, the company has grown to become a national-level large-scale securities company. As of the end of 2021, the company had a registered capital of 9.6 billion yuan and more than 12,000 employees. It has 58 branches and 184 business departments in 118 cities and regions across the country, serving over 12 million customers. In 2021, the company achieved a net profit of over 10 billion yuan and ranked first in the industry in terms of completed IPO projects. | Corporate Officer/Principal | 01-01-2004 |
AnPac Bio-Medical Technology (Lishui) Co., Ltd.
 AnPac Bio-Medical Technology (Lishui) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fresh2 Group Ltd., AnPac Bio-Medical Technology (Lishui) Co., Ltd. is a Chinese biotechnology company. The private company is based in Lishui, China. AnPac Bio-Medical Technology (Lishui) Co. was founded in 2012 and operates as a biotechnology company. | Director/Board Member | - |
Eerdere bekende functies van Feng Guo
| Bedrijven | Functie | Einde |
|---|---|---|
| FRESH2 GROUP LIMITED | Director/Board Member | 03-10-2022 |
China Renaissance Capital Investment (China), Inc.
 China Renaissance Capital Investment (China), Inc. Investment ManagersFinance Part of China Renaissance Capital Investment, Inc., China Renaissance Capital Investment (China), Inc. is an alternative investment manager. The private company is based in Beijing, China. | Director/Board Member | 01-01-2017 |
Opleiding van Feng Guo
| Shanghai University of Finance & Economics | Graduate Degree |
| East China University of Political Science & Law | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FRESH2 GROUP LIMITED | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
China Renaissance Capital Investment (China), Inc.
China Renaissance Capital Investment (China), Inc. Investment ManagersFinance Part of China Renaissance Capital Investment, Inc., China Renaissance Capital Investment (China), Inc. is an alternative investment manager. The private company is based in Beijing, China. | Finance |
Guoxin Securities Co., Ltd.
Guoxin Securities Co., Ltd. Investment Banks/BrokersFinance Guoxin Securities Co., Ltd. is a Chinese comprehensive securities company that offers stock investment and trading services. The private company is based in China, specifically in Pudong, China. With over 20 years of development, the company has grown to become a national-level large-scale securities company. As of the end of 2021, the company had a registered capital of 9.6 billion yuan and more than 12,000 employees. It has 58 branches and 184 business departments in 118 cities and regions across the country, serving over 12 million customers. In 2021, the company achieved a net profit of over 10 billion yuan and ranked first in the industry in terms of completed IPO projects. | Finance |
| Jiaxing Zhijun Investment Management Co., Ltd. | |
AnPac Bio-Medical Technology (Lishui) Co., Ltd.
AnPac Bio-Medical Technology (Lishui) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fresh2 Group Ltd., AnPac Bio-Medical Technology (Lishui) Co., Ltd. is a Chinese biotechnology company. The private company is based in Lishui, China. AnPac Bio-Medical Technology (Lishui) Co. was founded in 2012 and operates as a biotechnology company. | Commercial Services |
